Forecast Of The Day: Number Of Retail Prescriptions Filled By CVS

+10.54%
Upside
79.76
Market
88.17
Trefis
CVS: CVS Health logo
CVS
CVS Health

What?

The Number Of Retail Prescriptions Filled By CVS Health (NYSE:CVS) rose from 1.42 billion in 2019 to 1.47 billion in 2020. Trefis expects the metric to rise to around 1.52 billion in 2021 and 1.58 billion in 2022.

Why?

Relevant Articles
  1. Should You Pick CVS Stock At $75 After A 6% Fall This Year?
  2. Is CVS Health Stock Undervalued At $70?
  3. Will CVS Health Stock Recover To Its Pre-Inflation Shock Highs of $110?
  4. Higher Costs To Weigh On CVS Health’s Q2?
  5. Should You Buy CVS Stock At $70?
  6. Will CVS Stock Rise Post Q1?

We expect growth to be driven by the addition of new stores and rising healthcare spending.

So What?

We think the projected growth is largely priced into CVS stock. We value CVS at about $99 per share, about 5% ahead of the current market price.

See Our Complete Analysis For CVS Health

What if you’re looking for a more balanced portfolio instead? Here’s a high-quality portfolio that’s beaten the market consistently since 2016.

Invest with Trefis Market Beating Portfolios
See all Trefis Price Estimates